中国药理学与毒理学杂志
中國藥理學與毒理學雜誌
중국약이학여독이학잡지
CHINESE JOURNAL OF PHARMACOLOGY AND TOXICOLOGY
2010年
1期
13-18
,共6页
张登科%郝伟%周旭辉%王绪轶%谌红献%向小军%苏巧荣%张宏卫%张剑
張登科%郝偉%週旭輝%王緒軼%諶紅獻%嚮小軍%囌巧榮%張宏衛%張劍
장등과%학위%주욱휘%왕서질%심홍헌%향소군%소교영%장굉위%장검
特麦角脲%海洛因依赖%受体%多巴胺D2
特麥角脲%海洛因依賴%受體%多巴胺D2
특맥각뇨%해락인의뢰%수체%다파알D2
terguride%heroin dependence%receptors,dopamine D2
目的 探讨特麦角脲治疗海洛因依赖的作用机制.方法 成年雄性SD大鼠,随机分为正常对照组、海洛因依赖形成期生理盐水干预组、海洛因依赖形成期特麦角脲干预组、复发期生理盐水干预组和复发期特麦角脲干预组;除正常对照组外,其余4组分别建立海洛因静脉自身给药和线索诱发复发模型,干预后灌注固定,留取各脑区切片,采用免疫组化和原位杂交技术,分别检测各脑区多巴胺D2受体蛋白和mRNA、强啡肽原蛋白、前强啡肽原mRNA表达水平.结果 伏核多巴胺D2受体蛋白在海洛因依赖形成期表达下调,在复发期表达上升,多巴胺D2受体基因表达与蛋白表达基本一致,特麦角脲可使复发期受体蛋白表达回降.杏仁核中央核多巴胺D2受体蛋白和基因表达在复发期上调,特麦角脲可使基因表达回降.前额叶多巴胺D2受体蛋白和基因表达在形成期上调,蛋白表达在复发期下调,特麦角脲使复发期基因表达下调.伏核强啡肽蛋白和基因在复发期表达上调,特麦角脲使之回降.杏仁核中央核强啡肽蛋白在复发期表达上调,特麦角脲使之回降.结论 海洛因依赖形成期中脑边缘系统多巴胺活动升高,复发期活动降低,特麦角脲对此有双向调节作用.复发期强啡肽活动上升,特麦角脲可使之降低,有治疗海洛因滥用的潜力.
目的 探討特麥角脲治療海洛因依賴的作用機製.方法 成年雄性SD大鼠,隨機分為正常對照組、海洛因依賴形成期生理鹽水榦預組、海洛因依賴形成期特麥角脲榦預組、複髮期生理鹽水榦預組和複髮期特麥角脲榦預組;除正常對照組外,其餘4組分彆建立海洛因靜脈自身給藥和線索誘髮複髮模型,榦預後灌註固定,留取各腦區切片,採用免疫組化和原位雜交技術,分彆檢測各腦區多巴胺D2受體蛋白和mRNA、彊啡肽原蛋白、前彊啡肽原mRNA錶達水平.結果 伏覈多巴胺D2受體蛋白在海洛因依賴形成期錶達下調,在複髮期錶達上升,多巴胺D2受體基因錶達與蛋白錶達基本一緻,特麥角脲可使複髮期受體蛋白錶達迴降.杏仁覈中央覈多巴胺D2受體蛋白和基因錶達在複髮期上調,特麥角脲可使基因錶達迴降.前額葉多巴胺D2受體蛋白和基因錶達在形成期上調,蛋白錶達在複髮期下調,特麥角脲使複髮期基因錶達下調.伏覈彊啡肽蛋白和基因在複髮期錶達上調,特麥角脲使之迴降.杏仁覈中央覈彊啡肽蛋白在複髮期錶達上調,特麥角脲使之迴降.結論 海洛因依賴形成期中腦邊緣繫統多巴胺活動升高,複髮期活動降低,特麥角脲對此有雙嚮調節作用.複髮期彊啡肽活動上升,特麥角脲可使之降低,有治療海洛因濫用的潛力.
목적 탐토특맥각뇨치료해락인의뢰적작용궤제.방법 성년웅성SD대서,수궤분위정상대조조、해락인의뢰형성기생리염수간예조、해락인의뢰형성기특맥각뇨간예조、복발기생리염수간예조화복발기특맥각뇨간예조;제정상대조조외,기여4조분별건립해락인정맥자신급약화선색유발복발모형,간예후관주고정,류취각뇌구절편,채용면역조화화원위잡교기술,분별검측각뇌구다파알D2수체단백화mRNA、강배태원단백、전강배태원mRNA표체수평.결과 복핵다파알D2수체단백재해락인의뢰형성기표체하조,재복발기표체상승,다파알D2수체기인표체여단백표체기본일치,특맥각뇨가사복발기수체단백표체회강.행인핵중앙핵다파알D2수체단백화기인표체재복발기상조,특맥각뇨가사기인표체회강.전액협다파알D2수체단백화기인표체재형성기상조,단백표체재복발기하조,특맥각뇨사복발기기인표체하조.복핵강배태단백화기인재복발기표체상조,특맥각뇨사지회강.행인핵중앙핵강배태단백재복발기표체상조,특맥각뇨사지회강.결론 해락인의뢰형성기중뇌변연계통다파알활동승고,복발기활동강저,특맥각뇨대차유쌍향조절작용.복발기강배태활동상승,특맥각뇨가사지강저,유치료해락인람용적잠력.
OBJECTIVE To study mechanisms of terguride on the treatment of herion dependence. METHODS Adult male SD rats were randomly assigned into 5 groups: normal control group, saline treatment during heroin use period group, terguride treatment during heroin use period group, saline treatment during heroin reinstatement period group, terguride treatment during heroin reinstatement period group, the last 4 groups established heroin intravenous self administration and cue induced reinstatement models, and after interfernce and perfusion to get the following five brain regions [including ventral tegmental area (VTA)]sections. The expression of dopamine D2 receptor protein and mRNA, prodynorphin protein and preprodynorphin mRNA was detected by immunohistochemistry and hybridization in situ. RESULTS The expression of dopamine D2 receptor was downregulated during heroin use period and upregulated during heroin reinstatement period in nucleus accumbens shell (AcbSH) region, the expression of dopamine D2 receptor mRNA was parallelled with the protein expression approximately, terguride could downregulate the high expression of receptor protein during reinstatement. The expression of dopamine D2 receptor protein and mRNA was upregulated during heroin reinstatement period in central nucleus amygdalae (CeA) region, and terguride could downregulate this high expression. The expression of dopamine D2 receptor protein and mRNA was upregulated during heroin use period and downregulated during heroin reinstatement period in CA1 region of hippocampus and prefrontal cortex (PFC), terguride could downregulate the high expression of mRNA during heroin reinstatement period. The expression of dynorphin protein and mRNA was upregulated during heroin reinstatement period, terguride could downregulate this high expression. The expression of dynorphin protein was upregulated during heroin reinstatement period, and terguride could downregulate this high expression. CONCLUSION The activity of mesolimbic dopamine is boosted up during heroin use period and depressed during reinstatement period, terguride can regulate this dysregulation. The activity of dynorphin is boosted up during cue induced reinstatement, and terguride has the downregulation effect. So the preclinic study demonstrated that terguride has the potential benefit in heroin dependence.